We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

61 hedge funds and large institutions have $198M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 8

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

30% more funds holding

Funds holding: 47 → 61 (+14)

27% less capital invested

Capital invested by funds: $271M → $198M (-$73M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
61
Holders Change
+14
Holders Change %
+29.79%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
20
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$5.23M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.15M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.33M
4
Franklin Resources
Franklin Resources
California
+$2.33M
5
Northern Trust
Northern Trust
Illinois
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.18M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$3.38M
3
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
-$2.45M
4
KCM
Kingdon Capital Management
New York
-$2.14M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$52.5M +$4.15M +189,671 +9%
DM
2
Deerfield Management
New York
$44.2M -$108K -4,952 -0.2%
Millennium Management
3
Millennium Management
New York
$14.7M -$5.18M -236,796 -26%
Franklin Resources
4
Franklin Resources
California
$13.3M +$2.33M +106,300 +22%
Ameriprise
5
Ameriprise
Minnesota
$7.63M -$814K -37,195 -10%
JP Morgan Chase
6
JP Morgan Chase
New York
$7.04M +$5.23M +239,057 +310%
KCM
7
Kingdon Capital Management
New York
$6.77M -$2.14M -97,657 -24%
Jennison Associates
8
Jennison Associates
New York
$6.13M -$541K -24,722 -8%
WSA
9
Wall Street Associates
California
$5.01M – – –
BFA
10
BlackRock Fund Advisors
California
$4.52M -$398K -18,179 -8%
VAM
11
Visium Asset Management
New York
$4.09M -$1.09M -50,000 -21%
PI
12
Putnam Investments
Massachusetts
$3.65M -$15.3K -700 -0.4%
Vanguard Group
13
Vanguard Group
Pennsylvania
$3.2M +$2.33M +106,525 +288%
State Street
14
State Street
Massachusetts
$2.87M +$1.13M +51,712 +67%
DCM
15
Driehaus Capital Management
Illinois
$2.58M +$295K +13,476 +13%
BIT
16
BlackRock Institutional Trust
California
$2.35M +$242K +11,062 +12%
CAM
17
Cormorant Asset Management
Massachusetts
$2.23M – – –
Northern Trust
18
Northern Trust
Illinois
$2.14M +$1.39M +63,756 +197%
Wellington Management Group
19
Wellington Management Group
Massachusetts
$2.04M -$271K -12,410 -12%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$1.2M +$251K +11,476 +27%
TCIM
21
TIAA CREF Investment Management
New York
$1.12M +$446K +20,409 +68%
SM
22
Sabby Management
Florida
$1.11M +$1.09M +50,000 New
State of New Jersey Common Pension Fund D
23
State of New Jersey Common Pension Fund D
New Jersey
$967K +$949K +43,400 New
Morgan Stanley
24
Morgan Stanley
New York
$912K -$731K -33,419 -45%
DMK
25
David M. Knott
$788K +$774K +35,366 New
1
2 3

ASPX Hedge Fund Activity: Q2 2014 in Review

61 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2014, worth a combined $198M — down 27% from $271M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ASPX positions and 8 closed out — a net gain of 15 holders — while 20 added to existing stakes and 14 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $5.23M. The largest seller was Millennium Management, cutting an estimated $5.18M.

  • 61 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2014, up from 47 in Q1 2014.
  • Funds reported $198M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2014, down 27% quarter-over-quarter.
  • 23 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2014 and 8 closed out, a net change of +15 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2014 was JP Morgan Chase, an estimated $5.23M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2014 was Millennium Management, an estimated $5.18M sold.

Based on aggregated 13F filings for Q2 2014.